Saltar a la navegació principal
Saltar a la cerca
Vés al contingut principal
Ordenar per
Keyphrases
Abnormal Results
33%
Acceptance Level
50%
Adult Patients
33%
Adverse Drug Reaction
100%
Charlson Index
40%
Chronic Medication
100%
COVID-19
100%
Critically Ill Patients
100%
Depression Scale
33%
Dosing Recommendations
50%
Drug Dosing
100%
Drug Interactions
60%
Early Detection
33%
General Health Questionnaire
33%
HCV Patients
33%
Healthcare Professionals
62%
Hepatitis C
33%
Hospital Anxiety
33%
Hospitalization
62%
Immunosuppression Management
100%
Integrated Patient Care
33%
Intensive Care Unit
45%
Interferon-α (IFN-α)
100%
Medical Staff
50%
Medication Omission
50%
Multicenter Cohort Study
100%
Multidisciplinary Approach
100%
Multidisciplinary Monitoring
33%
Multimorbidity Patterns
100%
Older Patients
100%
Outpatient Pharmacy
33%
Patient Report
33%
Pharmaceutical Intervention
50%
Pharmacy Services
33%
Polypharmacy
37%
Potentially Inappropriate Medication
100%
Prescribing Drugs
100%
Retrospective Analysis
33%
Retrospective Cohort Study
100%
Ribavirin
100%
Screening Tool
37%
Self-administered Questionnaire
33%
Solid Organ Transplant Recipients
100%
Solid Organ Transplantation
100%
Surgical Patients
100%
Therapeutic Group
75%
Transplant Recipients
40%
Treatment Adherence
100%
Underlying Pathology
50%
Virological Response
33%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Drug Reaction
100%
Anticoagulant Agent
100%
Antiinfective Agent
100%
Antiviral Drug
100%
Chronic Disease
40%
Clinical Research
20%
Clinical Trial
100%
Critical Illness
100%
Fatality
20%
Hepatitis C
50%
Hospital Pharmacy
100%
Hypertensive Factor
100%
Immunosuppressive Agent
100%
Interferon
100%
Isoniazid
100%
Multiple Chronic Conditions
100%
Neuromuscular Blocking Agent
100%
Polypharmacy
60%
Prevalence
100%
Prospective Cohort Study
100%
Prospective Study
100%
Ribavirin
100%
Side Effect
50%
Syndrome
20%
Tic
20%
Medicine and Dentistry
Adverse Drug Reaction
100%
Bivariate Analysis
12%
Charlson Comorbidity Index
66%
Chronic Disease
25%
Clinical Research
12%
Cluster Analysis
12%
COVID-19
100%
Disease
25%
Drug Exposure
25%
Drug Interaction
100%
Fatality
12%
General Health Questionnaire
25%
Geriatric Syndrome
12%
Hepatitis C
25%
Hospital Anxiety and Depression Scale
25%
Immunosuppressant
66%
Immunosuppressive Treatment
100%
Infection
33%
Intensive Care Unit
33%
Interferon
100%
Mental Capacity
25%
Mental Disorder
100%
Multiple Chronic Conditions
100%
Multivariate Analysis
12%
Outpatient
25%
Patient Care
25%
Patient Compliance
75%
Polymerase Chain Reaction
33%
Polypharmacy
37%
Potentially Inappropriate Medication
100%
Prospective Cohort Study
100%
Retrospective Cohort Study
100%
Ribavirin
100%
Severe Acute Respiratory Syndrome Coronavirus 2
66%
Side Effect
25%
Solid Organ Transplantation
100%
Tertiary Care
33%
